• 제목/요약/키워드: pharmaceutical company

검색결과 179건 처리시간 0.028초

SELECTING NIR EQUIPMENT TO MEET THE STRATEGIC REQUIREMENTS OF A GLOBALIZED PHARMACEUTICAL COMPANY

  • Dowd, Chris;Horvath, Steve;Lonardi, Silvano;Salton, Neale;Scott, Chris;Viviani, Romeo
    • 한국근적외분광분석학회:학술대회논문집
    • /
    • 한국근적외분광분석학회 2001년도 NIR-2001
    • /
    • pp.3113-3113
    • /
    • 2001
  • Some two years ago our company undertook a project on manufacturing network rationalization to maximize competitiveness through continuous improvement in manufacturing efficiency. One key outcome was the recognition of the benefits that could be derived from timely application of new technology or novel use of existing technologies and even more importantly the need to develop company wide strategies to maximize the impact of such applications. As a direct result an exercise was undertaken to identify the ten most promising technologies from a list of literally hundreds seen as having the capability of making a rapid impact on the manufacturing initiative. One of the outcomes of this exercise was the identification of Near Infrared Spectroscopy as a pivotal technology for improving process understanding, performance, and control to deliver consistent product quality cost effectively with broad applicability across our product range. While NIR had been in use in targeted areas on some of our sites for some years our new challenge was to develop a strategy to extend NIRs application, initially over 17 manufacturing sites, while concurrently expanding the NIR skill base company wide to ensure that the return on initial investment could be further maximized as shared applications across the remaining sites as required. This presentation will provide an overview of how life cycle based user requirement specifications were developed covering: ㆍSpectrophotometers ㆍSample interfaces ㆍSoftware ㆍEquipment and Software qualification ㆍCalibration transfer ㆍ Ease of developing effective user interfaces and control for applications transferred to a production area ㆍUser training ㆍWorld wide support The presentation will also describe the process adopted for vendor selection to ensure maximum utilization of the existing company wide NIR skill base and its future development to expedite applications of the technology in development, quality control and production areas.

  • PDF

패널자료를 이용한 제약산업의 연구개발투자 결정요인분석: 외국인투자자와 기관투자가를 중심으로 (Analysis of the Determinants of Research and Development in the Pharmaceutical Industry Using Panel Study Focused Foreign and Institutional Investors)

  • 이문재;최만규
    • 보건의료산업학회지
    • /
    • 제9권3호
    • /
    • pp.247-254
    • /
    • 2015
  • Objectives : The aim of this study was to analyze the influence of foreign and institutional investors in the pharmaceutical industry on R&D investments. Methods : The empirical analysis was done for the years 2009 to 2013 which examined the period after the influence of the financial crisis. Financial statements and comments in general and internal transactions were extracted from the TS-2000 of the Korea Listed Company Association. STATA 12.0 was used as the statistical package for the panel analysis. Results : The results show that the shareholding ratio of foreigner investors turned out to have a statistically significant influence on R&D investment. No statistical significance was found in the shareholding ratio of institutional investors. Conclusions : The findings of this study, which indicate that a higher shareholding ratio of foreigner investors leads to greater R&D investment, indicate that foreign investors directly or indirectly impose pressure on a manager to make R&D investments for the long-term.

한약제제(漢藥製劑)의 면역학적(免疫學的) 연구(硏究) (제 1 보)(第 1 報) (Immunological Studies on Oriental Pharmaceutical Preparations (I))

  • 김병각;정경수;최응칠;김혜령;박희주;조필형
    • 생약학회지
    • /
    • 제14권3호
    • /
    • pp.125-129
    • /
    • 1983
  • To examine effects of oriental pharmaceutical preparations on immunity, four of such preparations which are currently being used were examined. After their fluid extracts were injected intraperitoneally to ICR mice, the counts of total cell number, PMN and macrophage in the peritoneal cavity were made by using non-specific esterase staining method, and plaque-forming cells (PFC) were measured by using the modified method of Cunningham and Jerne. The results showed that 'Bo-Jung-Ik-Ki-Tang', 'Ih-Jung-Tang', 'Ohn-Kyeong-Tang' and 'Ke-Ji-Bok-Ryeong-Hwan-Ka-Dae-Hwang' increased both the macrophages and the total cells of the peritoneal cavity and that these preparations increased the number of PFC in the spleen. Therefore the data indicate that they potentiate both of the cell­mediated and humoral immunities in the mice.

  • PDF

비즈니스 구성요소 분석을 통한 기업의 R&D 기술포트폴리오 가치평가모델 (Development of an Evaluation Model for R & D Technology Portfolio Based on Business Model Components)

  • 김영태;임광혁;이상철;박상찬
    • 품질경영학회지
    • /
    • 제40권3호
    • /
    • pp.372-380
    • /
    • 2012
  • Purpose: The purpose of this research is to develop the methods for evaluating the business value of a company's technical portfolios. In this study, technical portfolios of 10 major manufacturers and e-Biz industries are examined first from a business model perspective. Subsequently, we suggest future direction of R&D for the pharmaceutical industry by deducing the leading industries sharing similar traits with the pharmaceutical industry. Methods: In order to evaluate and analyze the patents of the major leading industries based on the constituents of a business model, the target patents were selected through the following procedure. Results: First, In this study, using the data obtained from the patent analysis, the differences in the technology portfolios of specific business entities based on the constituents of their business models. Second, deduced business rules of particular business entities through classification analysis and role-model of pharmaceutical industry Conclusion: If enterprise discovers technological change and characters of other enterprise or technology, enterprise could judge a direction of technology which will be developed in the near term and a plan which utilized existing technology to increase enterprise's profits.

우리나라 일부 의학 학술지에 게재된 의약품 광고의 과학적 근거에 대한 평가 (Quality of the pharmaceutical advertisement claims in five medical journals in Korea)

  • 안성복;최원;김철준;최성준;이강희;하경수;김현창
    • 한국의료질향상학회지
    • /
    • 제12권1호
    • /
    • pp.52-61
    • /
    • 2006
  • Background : The promotion and advertisement of pharmaceuticals should be based on evidence from clinical trials. We conducted this study to assess whether the pharmaceutical advertisement claims in Korean medical journals had relevant references, and whether the claims were supported by the references. Methods : We reviewed pharmaceutical advertisements in five Korean medical journals issued during the first half of 1999 and during the first half of 2004. Three investigators independently reviewed the advertisements to see whether the studies quoted to endorse the advertising messages supported the corresponding claims. Using multiple logistic regression analyses, we investigated which factors were associated with the quality of the advertisement claims. Results : From the 550 advertisements in the five journals, we identified 157 different advertisements and 475 different promotional claims. Only 149 claims had at least one reference, and 105 claims had references of published article. We could find supporting evidences in the 90 claims. The factors which were associated with the quality of advertisement claims were category of drugs, category of claims, and the manufacturer characteristics. Claims for cardiovascular and endocrine drugs, and claims on efficacy, and claims of multinational company were more evidence-based. Conclusion : Majority of the pharmaceutical advertisement claims in Korea did not have appropriate references. Drug category, claim category, and the manufacturer characteristics were associated with the quality of advertisement claims, and the manufacturer characteristics was the most important determinants.

  • PDF

Induction of Cytotoxicity and Apoptosis in Human Gastric Cancer Cell SGC-7901 by Isovaltrate Acetoxyhydrin Isolated from Patrinia heterophylla Bunge Involves a Mitochondrial Pathway and G2/M Phase Cell Cycle Arrest

  • Yang, Bo;Wang, Yi-Qi;Cheng, Ru-Bin;Chen, Jia-Li;Chen, Jin;Jia, Li-Tao;Zhang, Ru-Song
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권11호
    • /
    • pp.6481-6486
    • /
    • 2013
  • Background: Our previous study demonstrated cytotoxicity of a crude extract from Patrinia heterophylla Bunge (PHEB). In the present study, we aimed to investigate the effects of isovaltrate acetoxyhydrin (IA) isolated from PHEB on the gastric cancer cell SGC-7901, in order to explore a potential treatment for gastric cancer. Methods: MTT assays were employed to determine the effects of IA on cell vitality and proliferation, with monitoring of cell morphology changes and examination of apoptosis with Annexin V-PI staining. Flow cytometry was used to assess cell cycle progression and mitochondrial membrane potential. The activity of caspase 3, 9 was evaluated by spectrophotometry, and the protein levels of Bax, Bcl2 and Cyclin B1 were analyzed with Western blotting of total proteins extracted from cultured cells. Results: The results demonstrated direct toxicity of IA towards SGC-7901 cells. Evidence of apoptosis included blebbing and chromatin condensation. Annexin V-PI assays revealed early apoptosis, involving rapid depolarization of mitochondrial membranes and activity of caspase 3, 9 signaling pathways. Western blotting showed that Bcl2 and Bax proteins was down- and up-regulated, respectively, and cyclin B1 was up-regulated. Cell cycle analysis further indicated that IA could induce G2/M phase arrest in SGC-7901 cells. Conclusions: In conclusion, we believe that IA induces apoptosis of SGC-7901 cells, therefore providing a potential therapeutic agent for treatment of gastric cancer.

공정분석기술: 제약산업에서의 기술개발 사례 및 현황 (Process analytical technology (PAT): field applications and current status in pharmaceutical industries)

  • 우영아;김종윤;박용준;연제원;송규석;김효진
    • 분석과학
    • /
    • 제22권1호
    • /
    • pp.35-43
    • /
    • 2009
  • 단순히 완제품만을 평가하는 기존의 방법에서 제조 공정의 보다 깊은 이해와 공정 제어를 통한 품질 확보가 PAT (공정분석기술, process analytical technology)가 지향하고 있는 핵심이다. 생산 상 위험 요소가 많이 발생하는 공정을 제어할 수 있는 목적으로 새로운 실시간 공정 제어 기술을 개발하는 것이 PAT 연구 내용이다. 공정 단계에 대한 이해, 공정에 필요한 여러 가지 변수 및 공정 생산품의 평가 기술은 PAT를 수행하기 위한 기술적 핵심 요소이다. 이에 관련하여 다국적 제약회사의 실제 공정에서의 실시간 품질관리 사례는 상당히 많은 것으로 알려져 있으나, 제조공정 및 분석 기술 자체가 기업 비밀인 경우가 많아 관련 정보는 극히 제한되어 있다. 본 총설을 통하여 실제 제약 산업 현장에서 활용되고 있는 적용사례를 소개하고, 각 제조 공정 및 완제품 실시간 품질 관리를 위한 PAT 연구 사례 및 기술개발 현황에 대하여 언급하고자 한다.

전문의약품 마케팅활동의 효과 측정에 관한 실증 연구 (An Empirical Study on the Effectiveness of Marketing Activities for Ethical Drugs (ETC))

  • 노승연;김건우;장남식
    • 아태비즈니스연구
    • /
    • 제14권4호
    • /
    • pp.289-303
    • /
    • 2023
  • Purpose - The purpose of this study is to investigate the types and forms of various marketing activities actually used in pharmaceutical companies and to empirically analyze the impact of these marketing activities on sales. Design/methodology/approach - This study categorize five years' worth of marketing activity data from a foreign pharmaceutical company 'A' which operates in South Korea into five categories. Multiple regression analysis and interaction effects are employed for data analysis. Findings - First, CRM calls, Detail calls, GP, and Web events have a positive impact on sales, but SoV does not show significant differences. Second, in the comparison between HQ1 and HQ2 based on patent ownership, Detail calls and Web events had a stronger impact on sales in HQ2, where the patent period is still in effect, compared to HQ1. However, SoV showed no difference between HQ1 and HQ2. Research implications or Originality - First, Detail Calls are more effective for drugs with active patents, while CRM Calls work better for drugs with expired patents. This emphasizes the need to customize call strategies based on patent status. Second, the significant impact of Web Events on sales in HQ2 compared to HQ1 suggests that online information access is crucial, indicating that customer receptivity varies based on product nature. Third, these insights, derived from data analysis, call for a shift in pharmaceutical marketing analysis methods away from traditional approaches. Finally, this study holds significance as one of the first empirical analyses using actual marketing data from pharmaceutical companies in South Korea.

An Approach to Isolation of Thromboxane Synthase (TX-SYN) by Ligand Tethered Affinity Techniques

  • Andersen Niels H.;Rhee Jaekeol
    • Bulletin of the Korean Chemical Society
    • /
    • 제13권2호
    • /
    • pp.119-122
    • /
    • 1992
  • The affinity chromatographic technique was applied to the isolation of Thromboxane Synthase, with a variety of imidazolyl alkanoic acids coupled Sepharose 2B including a gel (G in Table 4) which has one free COOH group in the bound affinity ligand. The effect of ligand structure on the "affinity" and "selectivity" for thromboxane synthase isolation is described.

KHP 기준에 의한 보험용 단미엑스산제의 지표성분함량 확인연구 (A quantitative analysis of marker compounds in single herb extracts by the standard of KHP)

  • 박상준;김소형;김경석;김효선;이아영;김호경;김윤경
    • 대한본초학회지
    • /
    • 제29권3호
    • /
    • pp.35-42
    • /
    • 2014
  • Objectives : Since single extract powders was released at 1987, the insurance fee has not been changed, but the price of raw material has been increasing. According to this, Pharmaceutical company couldn't invest on quality of the product, so, the quality of single extracts went down and lost the consumer's trust. We checked the contents of marker ingredients in single extract thereby to recover the reliability of insurance-covered herbal preparations. Methods : we bought total twelve products of eight different single extracts of two main pharmaceutical companies among total 65 kinds of single extract powder stipulated in KHP (The Korean Herbal Pharmacopoeia) monograph III at Jan. 2013. Assays of selected single extract powders are performed by KHP regulation. And we surveyed price fluctuation of relevant herb raw materials from 2005 to 2012. Results : Among twelve products, eight single extract powders were suitable by the KHP regulation. But four products didn't reach the content amount of KHP. Marker contents in the single extracts product of Pueraria Root, Licorice, Peony root and Scutellaria Root of A company were 70%, 1%, 23.7% and 75.1%, respectively. Conclusions : We can acertain whether there's a quality problem in the insurance-covered single extract powders. But, A company is no longer producing these improper single extract powders. As a medicine, single extract powders needs to be strictly quality controlled by the company, and regularly monitored by the KFDA.